053950 — Kyung Nam Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
KR₩58bn
Enterprise Value
KR₩43bn
Revenue
KR₩61bn

Annual balance sheet for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,495	23,248	45,478	35,013	50,814
Net Total Accounts Receivable
Net Total Receivables	19,692	16,451	13,945	19,443	14,360
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57,639	54,920	77,329	71,198	77,825
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32,227	33,852	31,235	46,710	32,327
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	126,655	125,307	138,269	166,609	166,584
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38,605	25,411	43,887	66,933	46,279
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	69,291	52,778	44,498	87,248	51,361
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	57,364	72,529	93,771	79,362	115,223
Total Liabilities & Shareholders' Equity	126,655	125,307	138,269	166,609	166,584
Total Common Shares Outstanding